Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Immuno-Oncology Congress 2023

Cell therapy vs bispecific antibodies

Second vote and conclusions

Date

06 Dec 2023

Session

Cell therapy vs bispecific antibodies

Topics

Immunotherapy

Tumour Site

Presenters

E.G. Elisabeth de Vries

Authors

E.G..E. de Vries

Author affiliations

  • UMCG - University Medical Center Groningen, Groningen/NL

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction and first vote

Presenter: E.G. Elisabeth de Vries

Session: Cell therapy vs bispecific antibodies

Resources:

Slides

Webcast

Bispecific antibodies

Presenter: Martin Hutchings

Session: Cell therapy vs bispecific antibodies

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.